SCNI
Scinai Immunotherapeutics
SCNI
SCNI
10 hedge funds and large institutions have $309K invested in Scinai Immunotherapeutics in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$14.9K |
2 |
![]()
2
RhumbLine Advisers
Boston,
Massachusetts
|
$4.76K |
Top Sellers
1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$269K |
2 |
2
Millennium Management
New York
|
$15.7K |
3 |
VF
3
Virtu Financial
New York
|
$0 |
4 |
4
UBS Group
Zurich,
Switzerland
|
$431 |
5 |
5
Morgan Stanley
New York
|
$3.08K |